Where does KromaTiD's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across KromaTiD's 5 recorded funding rounds.

Premier Alternatives

KromaTiD

Longmont, CO · Founded 2007 · Privately Held (backing)

Developer of next-gen cytogenetic products focused on discovering, detecting, and diagnosing genomic rearrangements in the areas of oncology and rare diseases. KromaTiD is based in Longmont, CO and was founded in 2007. It was valued at $39 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $23.6 million across 5 recorded rounds; the latest was a $3.6 million seed round in Jul 2025.

PMV mark · valuation

$39.0M

Oct 2026

Priced at

its later-stage round

Jul 2025

Total raised

$23.6M

Last round

Seed Round

Jul 2025

Cap table — not yet on record

KromaTiD's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of KromaTiD with a free account

·The complete investor list: 11 names
·Watch KromaTiD: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about KromaTiD

Where does KromaTiD's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across KromaTiD's 5 recorded funding rounds.